医学
超声造影
前列腺癌
荟萃分析
放射科
活检
前列腺
前列腺活检
超声波
前列腺特异性抗原
经直肠超声检查
癌症
内科学
作者
Ming Zhang,Qingsong Meng,Lulu Feng,Dongbin Wang,Changbao Qu,Hui Tian,Jianghua Jia,Qinglu Gao,Xin Wang
出处
期刊:Medicine
[Wolters Kluwer]
日期:2022-12-23
卷期号:101 (51): e32404-e32404
被引量:12
标识
DOI:10.1097/md.0000000000032404
摘要
BACKGROUND: Conventional transrectal ultrasonography (TRUS) guided prostate biopsy is the standard method for accurate diagnosis of prostate cancer (PCa). However, the limitations of this technique in terms of missed diagnosis cannot be ignored. Based on previous studies, contrast-enhanced ultrasound (CEUS) may be able to more distinctly detect malignant lesions with increased microvessels. Therefore, to evaluate the diagnostic efficiency and clinical application prospects of CEUS-guided prostate biopsy for patients with suspected PCa, we performed a meta-analysis comparing CEUS-targeted with TRUS-guided systematic biopsy. METHODS: A systematic search of PubMed, Web of Science, Embase and CNKI was performed up to March, 2022 for the relevant published studies. After data extraction and quality assessment, meta-analysis was performed using the RevMan 5.3 software. RESULTS: The results showed that the overall sensitivity was higher for CEUS targeted biopsy than systematic biopsy (P = .03), so was the accuracy (P = .03). However, significant heterogeneity and inconsistent results from certain subgroup analyses challenged the validity of the results. Meanwhile, CEUS yielded a much higher sensitivity in patients with prostate specific antigen (PSA) level of 4 to 10 ng/mL (P = .007). On the other hand, the positive rate of each core (P < .001) and the detection rate of clinically significant PCa (P = .006) were significantly improved using CEUS. CONCLUSION: CEUS showed the advantage of a higher detection rate of clinically significant PCa, which might provide more specific indications for subsequent treatment. More feasible, real-time data are required to confirm our findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI